Follow
Marco Antonio Mendoza Parra
Marco Antonio Mendoza Parra
CNRS
Verified email at genoscope.cns.fr - Homepage
Title
Cited by
Cited by
Year
Senescence-associated reprogramming promotes cancer stemness
M Milanovic, DNY Fan, D Belenki, JHM Däbritz, Z Zhao, Y Yu, JR Dörr, ...
Nature 553 (7686), 96-100, 2018
6362018
Spo11-accessory proteins link double-strand break sites to the chromosome axis in early meiotic recombination
S Panizza, MA Mendoza, M Berlinger, L Huang, A Nicolas, K Shirahige, ...
Cell 146 (3), 372-383, 2011
3332011
Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity
MG Mendoza-Ferri, CG Hartinger, MA Mendoza, M Groessl, AE Egger, ...
Journal of medicinal chemistry 52 (4), 916-925, 2009
1872009
Single-tube linear DNA amplification (LinDA) for robust ChIP-seq
P Shankaranarayanan, MA Mendoza-Parra, M Walia, L Wang, N Li, ...
Nature methods 8 (7), 565-567, 2011
1362011
The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer
R Chaligné, T Popova, MA Mendoza-Parra, MAM Saleem, D Gentien, ...
Genome research 25 (4), 488-503, 2015
1252015
Dissecting the retinoid‐induced differentiation of F9 embryonal stem cells by integrative genomics
MA Mendoza‐Parra, M Walia, M Sankar, H Gronemeyer
Molecular systems biology 7 (1), 538, 2011
922011
A quality control system for profiles obtained by ChIP sequencing
MA Mendoza-Parra, W Van Gool, MA Mohamed Saleem, DG Ceschin, ...
Nucleic acids research 41 (21), e196-e196, 2013
442013
Statistical genomics: methods and protocols
E Mathé, S Davis
Humana Press, 2016
422016
CBP and P300 regulate distinct gene networks required for human primary myoblast differentiation and muscle integrity
L Fauquier, K Azzag, MAM Parra, A Quillien, M Boulet, S Diouf, G Carnac, ...
Scientific reports 8 (1), 1-16, 2018
352018
Single-tube linear DNA amplification for genome-wide studies using a few thousand cells
P Shankaranarayanan, MA Mendoza-Parra, W Van Gool, LM Trindade, ...
Nature Protocols 7 (2), 328-339, 2012
342012
The retinoids: biology, biochemistry, and disease
P Dollé, K Niederreither
John Wiley & Sons, 2015
292015
Reconstructed cell fate–regulatory programs in stem cells reveal hierarchies and key factors of neurogenesis
MA Mendoza-Parra, V Malysheva, MAM Saleem, M Lieb, A Godel, ...
Genome Research 26 (11), 1505-1519, 2016
232016
Senescence‐secreted factors activate M yc and sensitize pretransformed cells to TRAIL‐induced apoptosis
J Vjetrovic, P Shankaranarayanan, MA Mendoza‐Parra, H Gronemeyer
Aging cell 13 (3), 487-496, 2014
232014
Genome-wide studies of nuclear receptors in cell fate decisions
MA Mendoza-Parra, H Gronemeyer
Seminars in cell & developmental biology 24 (10-12), 706-715, 2013
222013
Characterising ChIP-seq binding patterns by model-based peak shape deconvolution
MA Mendoza-Parra, M Nowicka, W Van Gool, H Gronemeyer
BMC genomics 14 (1), 1-10, 2013
212013
Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis
V Malysheva, MA Mendoza-Parra, MAM Saleem, H Gronemeyer
Genome medicine 8 (1), 1-16, 2016
202016
Modeling gene-regulatory networks to describe cell fate transitions and predict master regulators
PE Cholley, J Moehlin, A Rohmer, V Zilliox, S Nicaise, H Gronemeyer, ...
NPJ systems biology and applications 4 (1), 29, 2018
172018
CDYL2 epigenetically regulates MIR124 to control NF-κB/STAT3-dependent breast cancer cell plasticity
M Siouda, AD Dujardin, L Barbollat-Boutrand, MA Mendoza-Parra, ...
Iscience 23 (6), 101141, 2020
142020
NGS-QC generator: a quality control system for ChIP-Seq and related deep sequencing-generated datasets
MA Mendoza-Parra, MAM Saleem, M Blum, PE Cholley, H Gronemeyer
Statistical Genomics: Methods and Protocols, 243-265, 2016
142016
POLYPHEMUS: R package for comparative analysis of RNA polymerase II ChIP-seq profiles by non-linear normalization
MA Mendoza-Parra, M Sankar, M Walia, H Gronemeyer
Nucleic acids research 40 (4), e30-e30, 2012
132012
The system can't perform the operation now. Try again later.
Articles 1–20